Robert Maiorana - Oasmia Pharmaceutical Head CFO
| OASMYDelisted Stock | USD 0.06 0.00 0.00% |
Insider
Robert Maiorana is Head CFO of Oasmia Pharmaceutical AB
| Age | 63 |
| Phone | 46 18 50 54 40 |
| Web | https://www.vivesto.com |
Oasmia Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of (0.0875) % which means that it has lost $0.0875 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2542) %, meaning that it generated substantial loss on money invested by shareholders. Oasmia Pharmaceutical's management efficiency ratios could be used to measure how well Oasmia Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Joseph Margolis | Invitation Homes | 60 | |
| Xin Fan | Autohome | N/A | |
| David Verret | Live Ventures | 50 | |
| Junlin Liu | Autohome | 54 | |
| Thomas Sedlak | Live Ventures | 53 | |
| Jay Porter | Westrock Coffee | N/A | |
| Megan Pelletier | HomeTrust Bancshares | 46 | |
| Joe Ford | Westrock Coffee | 87 | |
| Jun Lu | Autohome | N/A | |
| Kim Norrell | Invitation Homes | N/A | |
| Hong Jiang | Autohome | N/A | |
| William Ford | Westrock Coffee | 30 | |
| Bonnie Zelwak | HomeTrust Bancshares | N/A | |
| Jing Xiao | Autohome | 47 | |
| Jingyu Zhang | Autohome | 46 | |
| Yan Zeng | Autohome | 57 | |
| Rodney Spriggs | Live Ventures | 58 | |
| Elizabeth Galloway | Invitation Homes | 45 | |
| Blake Schuhmacher | Westrock Coffee | 47 | |
| Timothy Matula | Live Ventures | 64 | |
| John Gibson | Invitation Homes | N/A | |
Management Performance
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0875 |
Oasmia Pharmaceutical Leadership Team
Elected by the shareholders, the Oasmia Pharmaceutical's board of directors comprises two types of representatives: Oasmia Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oasmia. The board's role is to monitor Oasmia Pharmaceutical's management team and ensure that shareholders' interests are well served. Oasmia Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oasmia Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kai Wilkinson, Chief Officer | ||
| Urban Ekelund, IR Mang | ||
| Henrik Rnnberg, Chief Health | ||
| John Cosby, Head Affairs | ||
| Robert Maiorana, Head CFO | ||
| Dzianis Babrou, Head Devel | ||
| Christer MD, Acting Officer | ||
| Reinhard Koenig, Chief Officer | ||
| Johanna Rostin, Head Affairs | ||
| Maria Hagberg, Head Affairs |
Oasmia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Oasmia Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0875 | ||||
| Current Valuation | 6.58 M | ||||
| Shares Outstanding | 179.35 M | ||||
| Number Of Shares Shorted | 20.72 K | ||||
| Price To Book | 0.68 X | ||||
| Price To Sales | 31.16 X | ||||
| Revenue | 26.19 M | ||||
| Gross Profit | (15.25 M) | ||||
| EBITDA | (97.54 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |